RCT of Gastric ESD With or Without Epineprhine Added Solution

Summary

This is an international multi-center randomised controlled study comparing outcomes of gastric endoscopic submucosal dissection (ESD) with or without addition of epinephrine in the submucosal injection solution.

Conditions

• Gastric Neoplasm
• Early Gastric Cancer

Interventions

PROCEDURE

Endoscopic submucosal dissection

Endoscopic submucosal dissection

DRUG

Epinephrine

Epinephrine

Sponsors & Collaborators

• Osaka International Cancer Institute

  collaborator UNKNOWN

• Fukuoka University

  collaborator OTHER

• Changi General Hospital

  collaborator OTHER

• Kyoto 2nd Red Cross Hospital

  collaborator UNKNOWN

• Ishikawa Prefectural Central Hospital

  collaborator UNKNOWN

• Kosin University Gospel Hospital

  collaborator OTHER

• Machida General Hospital

  collaborator UNKNOWN

• Nara City Hospital

  collaborator UNKNOWN

• Wakayama Red Cross Hospital

  collaborator UNKNOWN

• JCHO Osaka Hospital

  collaborator UNKNOWN

• Sapporo Kinentou hospital

  collaborator UNKNOWN

• Japan Community Healthcare Organization Osaka Hospital

  collaborator UNKNOWN

• Chinese University of Hong Kong

  lead OTHER

Principal Investigators

• Hon Chi Yip, MBChB, FRCSEd · Chinese University of Hong Kong

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Model

PARALLEL

Eligibility

Min Age

20 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2020-01-10

Primary Completion

2022-12-31

Completion

2023-01-31

Countries

• Hong Kong
• Japan
• Singapore
• South Korea

Study Locations